DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Akero Therapeutics Q4 EPS $(0.55)

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.55) per share.

Benzinga · 03/16/2020 11:38

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.55) per share.